| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.357 | 0.037 | 0.376 | Antiamyloidogenic | 0.376 0.033 DBMET02126 | DBMET02126 | |
| 0.197 | 0.02 | 0.197 | Nav1.6 sodium channel blocker | |||
| 0.209 | 0.033 | 0.209 | Cytokine production inhibitor | 0.168 0.05 DBMET02126 | ||
| 0.203 | 0.029 | 0.203 | MAP kinase kinase 5 inhibitor | 0.197 0.037 DBMET02126 | ||
| 0.186 | 0.04 | 0.186 | Nav1.2 sodium channel blocker | |||
| 0.186 | 0.059 | 0.21 | Thrombolytic | 0.21 0.047 DBMET02126 | DBMET02126 | |
| 0.203 | 0.076 | 0.311 | Amyloid beta aggregation inhibitor | 0.311 0.043 DBMET02126 | DBMET02126 | |
| 0.206 | 0.081 | 0.243 | Interleukin antagonist | 0.243 0.064 DBMET02126 | DBMET02126 | |
| 0.128 | 0.059 | 0.128 | Beta amyloid protein antagonist | 0.1 0.089 DBMET02126 | ||
| 0.184 | 0.122 | 0.242 | Peptidyltransferase inhibitor | 0.242 0.056 DBMET02126 | DBMET02126 | |
| 0.097 | 0.038 | 0.097 | Myeloperoxidase inhibitor | 0.094 0.042 DBMET02126 | ||
| 0.218 | 0.16 | 0.281 | Interleukin 2 agonist | 0.281 0.088 DBMET02126 | DBMET02126 | |
| 0.181 | 0.125 | 0.181 | Tumour necrosis factor alpha release inhibitor | |||
| 0.103 | 0.049 | 0.103 | Interleukin 12 antagonist | 0.09 0.072 DBMET02126 | ||
| 0.145 | 0.092 | 0.323 | Heat shock protein 90 alpha antagonist | 0.323 0.011 DBMET02126 | DBMET02126 | |
| 0.201 | 0.149 | 0.221 | 5 Hydroxytryptamine uptake stimulant | 0.221 0.116 DBMET02126 | DBMET02126 | |
| 0.071 | 0.024 | 0.082 | Botulinum neurotoxin type A inhibitor | 0.082 0.016 DBMET02126 | DBMET02126 | |
| 0.132 | 0.095 | 0.309 | Heat shock protein 90 antagonist | 0.309 0.009 DBMET02126 | DBMET02126 | |
| 0.101 | 0.066 | 0.112 | Factor V inhibitor | 0.112 0.048 DBMET02126 | DBMET02126 | |
| 0.132 | 0.104 | 0.227 | Growth hormone agonist | 0.227 0.05 DBMET02126 | DBMET02126 | |
| 0.098 | 0.078 | 0.098 | Nav1.4 sodium channel blocker | |||
| 0.07 | 0.056 | 0.07 | Nav1.8 sodium channel blocker | |||
| 0.153 | 0.14 | 0.192 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.192 0.096 DBMET02126 | DBMET02126 | |
| 0.06 | 0.047 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.021 DBMET02126 | DBMET02126 | |
| 0.041 | 0.029 | 0.041 | Plasmepsin II inhibitor | 0.04 0.031 DBMET02126 | ||
| 0.117 | 0.105 | 0.117 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.238 | 0.228 | 0.355 | Apoptosis agonist | 0.355 0.136 DBMET02126 | DBMET02126 | |
| 0.097 | 0.09 | 0.097 | Electron transport complex I inhibitor | |||
| 0.194 | 0.188 | 0.25 | Apoptosis antagonist | 0.25 0.128 DBMET02126 | DBMET02126 | |
| 0.021 | 0.017 | 0.025 | Corticotropin releasing factor 1 receptor antagonist | 0.025 0.014 DBMET02126 | DBMET02126 | |
| 0.068 | 0.067 | 0.094 | Somatostatin 1 agonist | 0.094 0.038 DBMET02126 | DBMET02126 | |
| 0.115 | 0.124 | 0.174 | Hemostatic | 0.174 0.046 DBMET02126 | DBMET02126 | |
| 0.089 | 0.103 | 0.1 | MAO inhibitor | 0.1 0.091 DBMET02126 | DBMET02126 | |
| 0.106 | 0.126 | 0.124 | Papain-like protease (SARS coronavirus) inhibitor | 0.124 0.072 DBMET02126 | DBMET02126 | |
| 0.051 | 0.078 | 0.061 | Bcl-xL inhibitor | 0.061 0.036 DBMET02126 | DBMET02126 | |
| 0.168 | 0.205 | 0.193 | Transcription factor NF kappa B inhibitor | 0.193 0.176 DBMET02126 | DBMET02126 | |
| 0.084 | 0.138 | 0.159 | Toll-Like receptor 2 antagonist | 0.159 0.047 DBMET02126 | DBMET02126 | |
| 0.083 | 0.143 | 0.158 | Lipid peroxidase inhibitor | 0.158 0.063 DBMET02126 | DBMET02126 | |
| 0.185 | 0.248 | 0.43 | Antibacterial | 0.43 0.064 DBMET02126 | DBMET02126 | |
| 0.117 | 0.196 | 0.193 | Free radical scavenger | 0.193 0.104 DBMET02126 | DBMET02126 | |
| 0.159 | 0.244 | 0.256 | Immunosuppressant | 0.256 0.143 DBMET02126 | DBMET02126 | |
| 0.148 | 0.238 | 0.219 | Immunomodulator | 0.219 0.143 DBMET02126 | DBMET02126 | |
| 0.128 | 0.218 | 0.218 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 DBMET02126 | DBMET02126 | |
| 0.083 | 0.18 | 0.144 | Angiogenesis stimulant | 0.144 0.126 DBMET02126 | DBMET02126 | |
| 0.092 | 0.193 | 0.14 | Platelet adhesion inhibitor | 0.14 0.118 DBMET02126 | DBMET02126 | |
| 0.036 | 0.139 | 0.104 | Heat shock protein 90 beta antagonist | 0.104 0.01 DBMET02126 | DBMET02126 | |
| 0.047 | 0.16 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.081 0.06 DBMET02126 | DBMET02126 | |
| 0.049 | 0.2 | 0.089 | Nitric-oxide synthase inhibitor | 0.089 0.079 DBMET02126 | DBMET02126 | |
| 0.073 | 0.228 | 0.107 | Sphingosine 1-phosphate receptor 4 antagonist | 0.107 0.102 DBMET02126 | DBMET02126 | |
| 0.098 | 0.257 | 0.176 | Antioxidant | 0.176 0.136 DBMET02126 | DBMET02126 | |
| 0.075 | 0.25 | 0.147 | Neuropeptide Y1 antagonist | 0.147 0.069 DBMET02126 | DBMET02126 | |
| 0.043 | 0.223 | 0.177 | Chelator | 0.177 0.029 DBMET02126 | DBMET02126 | |
| 0.056 | 0.248 | 0.115 | Photosensitizer | 0.115 0.063 DBMET02126 | DBMET02126 | |
| 0.052 | 0.3 | 0.117 | T cell inhibitor | 0.117 0.015 DBMET02126 | DBMET02126 | |
| 0.033 | 0.29 | 0.147 | Alkylator | 0.147 0.048 DBMET02126 | DBMET02126 | |
| 0.028 | 0.311 | 0.103 | Topoisomerase II inhibitor | 0.103 0.083 DBMET02126 | DBMET02126 | |
| 0.136 | 0.449 | 0.269 | Caspase 9 stimulant | 0.269 0.23 DBMET02126 | DBMET02126 | |
| 0.099 | 0.443 | 0.173 | Nitric-oxide synthase stimulant | 0.173 0.146 DBMET02126 | DBMET02126 | |
| 0.041 | 0.389 | 0.192 | Immunostimulant | 0.192 0.125 DBMET02126 | DBMET02126 | |
| 0.042 | 0.505 | 0.213 | DNA damaging | 0.213 0.105 DBMET02126 | DBMET02126 | |
| 0.007 | 0.668 | 0.075 | CDC25A inhibitor | 0.075 0.049 DBMET02126 | DBMET02126 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |